Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors

被引：15

作者：

Clayette, P

Jorajuria, S

Dormont, D

机构：

[1] CEA, Serv Neurovirol, DSV, DRM, F-92265 Fontenay Aux Roses, France

[2] ZI de la Bonde, BIO, SPI, Massy, France

来源：

AIDS | 2000年 / 14卷 / 03期

关键词：

P-glycoprotein; HIV transmission; HIV protease inhibitor; blood-brain barrier; placenta;

D O I：

10.1097/00002030-200002180-00004

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：235 / 236

页数：2

共 5 条

[1] Interactions of HIV protease inhibitors with ATP-dependent drug export proteins [J].

Gutmann, H ;

Fricker, G ;

Drewe, J ;

Toeroek, M ;

Miller, DS .

MOLECULAR PHARMACOLOGY, 1999, 56 (02) :383-389

[2]

Huisman MT, 2000, AIDS, V14, P237, DOI 10.1097/00002030-200002180-00005

[3] P-170 GLYCOPROTEIN (P-170) IS INVOLVED IN THE IMPAIRMENT OF NATURAL-KILLER CELL-MEDIATED CYTOTOXICITY IN HIV+ PATIENTS [J].

LUCIA, MB ;

CAUDA, R ;

MALORNI, W ;

RAINALDI, G ;

TUMBARELLO, M ;

TACCONELLI, E ;

RUMI, C ;

DONELLI, G ;

ORTONA, L .

IMMUNOLOGY LETTERS, 1995, 47 (03) :223-226

[4] Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors [J].

Profit, L ;

Eagling, VA ;

Back, DJ .

AIDS, 1999, 13 (13) :1623-1627

[5] Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures [J].

Ziemann, C ;

Bürkle, A ;

Kahl, GF ;

Hirsch-Ernst, KI .

CARCINOGENESIS, 1999, 20 (03) :407-414

← 1 →